Anti-Müllerian Hormone Is a Marker of Gonadotoxicity in Pre- and Postpubertal Girls Treated for Cancer: A Prospective Study
Mark Brougham, William H. Wallace(Royal Hospital for Children), Emma Johnson(University of North Carolina at Chapel Hill), Richard A. Anderson(MRC Centre for Reproductive Health), Nancy Evans(MRC Centre for Reproductive Health), Patricia M. Crofton(Royal Hospital for Children)
Cited by 202
Related Papers
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group
|Pediatric Blood & Cancer|2012|361
Premature ovarian insufficiency: an International Menopause Society White Paper
|Climacteric|2020|274
Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis
|BMC Developmental Biology|2007|238
Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review
|Journal of Clinical Oncology|2018|230